Pricing pressures and regulatory overhang affect margins of Indian pharma companies in FY2023: ICRA Read more
We will maintain a growth rate in the high teens for both (CDMO and API business) in the next few years Read more
Alembic Pharma gets USFDA nod for Fulvestrant injection, 250 mg/5 mL per single-dose syringe Read more